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The concepts of equal versus equivalent access to
the scientific literature are discussed
In 1954, the United States Supreme Court in a landmark
decision of Brown vs. Board of Education of Topeka,
Kansas sharply repudiated the “separate but equal” prin-
ciple of public education. The Court concluded that
racially segregated education is “inherently unequal”. In
scientific publishing today, there exist two segregated
means of knowledge dissemination — the subscription
journals and the Open Access (OA) journals. For those
who can pay, there is immediate access to scientific
papers published in both subscription and OA journals;
those who cannot pay can access only OA journals. The
status quo is thus an “inherently unequal” playing field
between the “haves” and the “have nots”.
How unequal is the current situation? In an August 1,
2011 posting on the Nature News website, Richard Van
Noorden reported that “the proportion of research
papers freely available is slowly and steadily creeping
upwards... in 2009, it’s above 28%. (Some of this litera-
ture is not immediately available at the time that it is
published, because of journal policies that impose
embargo periods on when material can become free)”.
The good news is that approximately 30% of published
papers can be accessed freely. The bad news is that 70%
of published, publicly funded research remains off-limits
to those who cannot pay.
Can equal access be had by the “haves” and the “have
nots"? To the extent that the subscription and OA
tracks will likely co-exist, the foreseeable future is a
“separate and unequal” reality. Without equal access, the
next best goal is perhaps to achieve equivalent access.
What is equivalent access? Imagine two very similar
papers reaching essentially the same conclusions; one is
published in a subscription journal and the other pub-
lished in an OA journal. The paying reader can read
both papers; the non-paying person can read only the
OA paper. This is “unequal” access. However, if the OA
paper sufficiently conveys the same information as the
subscription paper, then it is possible that “equivalent”
knowledge is conveyed to both the can-pay and cannot-
pay audiences.
The equivalent access concept works only if subscrip-
tion and OA journals can attract and publish, in chron-
ological proximity, similar articles of comparable quality
and impact. Practically speaking, for this to occur, OA
journals need to achieve quality metrics (e.g. Impact
Factor numbers) that match their subscription counter-
parts. The Retrovirology experience suggests that such
benchmark can be achieved (Figure 1).
Achieving qualitative parity will go a long way towards
advancing equivalent access to important biological find-
ings. One could raise the recent XMRV-Chronic Fatigue
Syndrome controversy [1] as an example. A strongly
credible case can be made that OA readers who read
only Retrovirology papers [2-9] knowledgeably reached
the equivalent scientific conclusion regarding this topic
as those who read the subscription-based literature.
The quality of OA publishing will continue to
improve. In 2012, Cell will launch a top tier OA publi-
cation, Cell Reports; and the Wellcome Trust/the
Howard Hughes Medical Institute/the Max Planck
Society will also start a similarly high profile OA jour-
nal. Because intelligence and ambition are distributed
equally around the globe [10], freely available equivalent
access to timely knowledge matters. “Separate but
equivalent” may become the watchword of 21st century
publishing.
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Figure 1 Impact factor numbers from 2010 ISI-Thomson
Reuters data that compare Retrovirology with nine other
subscription journals. Seven of the nine journals publish basic
virological research papers. The Journal of Biological Chemistry and
the Journal of Molecular Biology are included for comparison to two
well-established journals that publish basic research papers in
biochemistry and molecular biology.
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